The COVID-19 road to recovery: coordinating clinical trial testing and central lab solutions

As COVID-19 was declared a pandemic, our Clinical Trials Testing Solutions (CTTS) witnessed a sudden influx of COVID-19 studies from both large pharmaceutical organizations and biotechs.

Clinical oversight during the COVID-19 pandemic: 5 reporting lessons learned

Clinical trial sponsors need the ability to monitor the health of their study or portfolio of studies on an ongoing basis.  In times of crises, this becomes a challenging task, as the rapidly evolving situation might render standard reporting tools inadequate and outdated. The Xcellerate® technology suite has been developed with the goal of accommodating the diverse reporting needs of sponsors that run trials with us, but the COVID-19 pandemic has been a unique situation.

Developing an effective reimbursement strategy – if you build it, will they come?

You and your team have been working hard to gain approval and successfully launch your device. However, you may be forgetting an important consideration for market success: reimbursement.

Expediting timelines and enhancing quality for central labs global study startup

For drug development sponsors running global studies, each day on the path to market is precious. To help support sponsors’ accelerated study startup, our Central Laboratory Services (CLS) has enhanced its core systems and technologies to significantly trim typical startup timelines up to four weeks, reduce the time to implement potential study modifications after startup up to two weeks, and improve the overall quality of delivery.

Exploring Decentralized Clinical Trials (DCTs) – a new monthly blog series

Welcome to the Decentralized Clinical Trials (DCTs) monthly blog.With patient-centric trial designs becoming a driving force in the drug development industry, we will be doing a series of monthly blogs that look back on recent events which give us insight into designing resilient clinical trials and ensuring study and data continuity. 

Addressing social determinants of health through preventive programs and community partnerships

Labcorp partners with community organizations to increase access to education, healthy foods and preventive healthcare services, such as health screenings, to improve health equity.

Urine drug testing for medication-assisted treatment (MAT)

Treatment professionals agree that monitoring drug use during MAT can be a powerful incentive for abstinence, and it can also help identify OUD relapse.